Literature DB >> 12869395

Point: Surrogate end point biomarkers are likely to be limited in their usefulness in the development of cancer chemoprevention agents against sporadic cancers.

William B Armstrong1, Thomas H Taylor, Frank L Meyskens.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12869395

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


× No keyword cloud information.
  2 in total

1.  The effectiveness of chemoprevention agents is underestimated when lesion sizes are rounded.

Authors:  Thomas H Taylor; William B Armstrong; Frank L Meyskens
Journal:  Cancer Prev Res (Phila)       Date:  2010-01-19

Review 2.  Chemoprevention of melanoma.

Authors:  Subbarao V Madhunapantula; Gavin P Robertson
Journal:  Adv Pharmacol       Date:  2012
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.